nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GSK3A—penis—type 1 diabetes mellitus	0.0707	0.195	CbGeAlD
Lithium—GRIA3—nerve—type 1 diabetes mellitus	0.0431	0.119	CbGeAlD
Lithium—GSK3B—nerve—type 1 diabetes mellitus	0.0374	0.103	CbGeAlD
Lithium—IMPA2—islet of Langerhans—type 1 diabetes mellitus	0.0184	0.051	CbGeAlD
Lithium—IMPA1—cardiovascular system—type 1 diabetes mellitus	0.0178	0.0491	CbGeAlD
Lithium—IMPA1—kidney—type 1 diabetes mellitus	0.0174	0.0481	CbGeAlD
Lithium—GSK3A—islet of Langerhans—type 1 diabetes mellitus	0.0157	0.0435	CbGeAlD
Lithium—IMPA1—lymphoid tissue—type 1 diabetes mellitus	0.0149	0.0413	CbGeAlD
Lithium—IMPA2—nephron tubule—type 1 diabetes mellitus	0.0149	0.041	CbGeAlD
Lithium—Psoriasis flare-up—Ramipril—type 1 diabetes mellitus	0.0144	0.223	CcSEcCtD
Lithium—GSK3A—retina—type 1 diabetes mellitus	0.0135	0.0372	CbGeAlD
Lithium—GSK3B—cardiovascular system—type 1 diabetes mellitus	0.0131	0.0362	CbGeAlD
Lithium—IMPA2—kidney—type 1 diabetes mellitus	0.0131	0.0361	CbGeAlD
Lithium—IMPA2—pancreas—type 1 diabetes mellitus	0.013	0.0358	CbGeAlD
Lithium—GSK3B—kidney—type 1 diabetes mellitus	0.0128	0.0354	CbGeAlD
Lithium—GSK3A—nephron tubule—type 1 diabetes mellitus	0.0127	0.035	CbGeAlD
Lithium—GSK3A—cardiovascular system—type 1 diabetes mellitus	0.0114	0.0314	CbGeAlD
Lithium—GSK3A—pancreas—type 1 diabetes mellitus	0.0111	0.0306	CbGeAlD
Lithium—GSK3B—lymphoid tissue—type 1 diabetes mellitus	0.011	0.0304	CbGeAlD
Lithium—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00419	0.0647	CcSEcCtD
Lithium—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.0028	0.0433	CcSEcCtD
Lithium—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00256	0.0395	CcSEcCtD
Lithium—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00238	0.0368	CcSEcCtD
Lithium—Polyuria—Ramipril—type 1 diabetes mellitus	0.00218	0.0336	CcSEcCtD
Lithium—Gastritis—Ramipril—type 1 diabetes mellitus	0.00169	0.0261	CcSEcCtD
Lithium—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00152	0.0235	CcSEcCtD
Lithium—Weight increased—Ramipril—type 1 diabetes mellitus	0.00151	0.0232	CcSEcCtD
Lithium—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00123	0.019	CcSEcCtD
Lithium—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00118	0.0182	CcSEcCtD
Lithium—Alopecia—Ramipril—type 1 diabetes mellitus	0.00117	0.018	CcSEcCtD
Lithium—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00113	0.0174	CcSEcCtD
Lithium—Tremor—Ramipril—type 1 diabetes mellitus	0.00108	0.0167	CcSEcCtD
Lithium—Agitation—Ramipril—type 1 diabetes mellitus	0.00106	0.0163	CcSEcCtD
Lithium—Angioedema—Ramipril—type 1 diabetes mellitus	0.00105	0.0162	CcSEcCtD
Lithium—Vertigo—Ramipril—type 1 diabetes mellitus	0.00104	0.016	CcSEcCtD
Lithium—Syncope—Ramipril—type 1 diabetes mellitus	0.00103	0.0159	CcSEcCtD
Lithium—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00101	0.0156	CcSEcCtD
Lithium—Convulsion—Ramipril—type 1 diabetes mellitus	0.000998	0.0154	CcSEcCtD
Lithium—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000981	0.0151	CcSEcCtD
Lithium—Discomfort—Ramipril—type 1 diabetes mellitus	0.000969	0.015	CcSEcCtD
Lithium—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00096	0.0148	CcSEcCtD
Lithium—Confusional state—Ramipril—type 1 diabetes mellitus	0.000948	0.0146	CcSEcCtD
Lithium—Oedema—Ramipril—type 1 diabetes mellitus	0.000941	0.0145	CcSEcCtD
Lithium—Shock—Ramipril—type 1 diabetes mellitus	0.000925	0.0143	CcSEcCtD
Lithium—Anorexia—Ramipril—type 1 diabetes mellitus	0.000896	0.0138	CcSEcCtD
Lithium—Hypotension—Ramipril—type 1 diabetes mellitus	0.000879	0.0136	CcSEcCtD
Lithium—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000857	0.0132	CcSEcCtD
Lithium—Somnolence—Ramipril—type 1 diabetes mellitus	0.000836	0.0129	CcSEcCtD
Lithium—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000828	0.0128	CcSEcCtD
Lithium—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000818	0.0126	CcSEcCtD
Lithium—Fatigue—Ramipril—type 1 diabetes mellitus	0.000811	0.0125	CcSEcCtD
Lithium—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000775	0.012	CcSEcCtD
Lithium—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000769	0.0119	CcSEcCtD
Lithium—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000743	0.0115	CcSEcCtD
Lithium—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000743	0.0115	CcSEcCtD
Lithium—Asthenia—Ramipril—type 1 diabetes mellitus	0.000675	0.0104	CcSEcCtD
Lithium—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000643	0.00993	CcSEcCtD
Lithium—Dizziness—Ramipril—type 1 diabetes mellitus	0.000622	0.0096	CcSEcCtD
Lithium—Vomiting—Ramipril—type 1 diabetes mellitus	0.000598	0.00923	CcSEcCtD
Lithium—Rash—Ramipril—type 1 diabetes mellitus	0.000593	0.00915	CcSEcCtD
Lithium—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000592	0.00914	CcSEcCtD
Lithium—Headache—Ramipril—type 1 diabetes mellitus	0.000589	0.00909	CcSEcCtD
Lithium—Nausea—Ramipril—type 1 diabetes mellitus	0.000559	0.00862	CcSEcCtD
Lithium—GSK3B—Signaling by FGFR in disease—STAT3—type 1 diabetes mellitus	0.000306	0.000534	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—VAV1—type 1 diabetes mellitus	0.000304	0.00053	CbGpPWpGaD
Lithium—IMPA2—Metabolism—NOS3—type 1 diabetes mellitus	0.000303	0.000529	CbGpPWpGaD
Lithium—GSK3A—Disease—B2M—type 1 diabetes mellitus	0.000302	0.000527	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—EGFR—type 1 diabetes mellitus	0.0003	0.000524	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—STAT3—type 1 diabetes mellitus	0.0003	0.000523	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—EGFR—type 1 diabetes mellitus	0.000299	0.000521	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—TYK2—type 1 diabetes mellitus	0.000298	0.00052	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—EGFR—type 1 diabetes mellitus	0.000297	0.000519	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—EGFR—type 1 diabetes mellitus	0.000296	0.000516	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000294	0.000513	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling events of B Cell Receptor (BCR)—EGFR—type 1 diabetes mellitus	0.000292	0.000509	CbGpPWpGaD
Lithium—GSK3A—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.00029	0.000505	CbGpPWpGaD
Lithium—GSK3A—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.00029	0.000505	CbGpPWpGaD
Lithium—GSK3A—DAP12 interactions—IL6—type 1 diabetes mellitus	0.00029	0.000505	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000289	0.000505	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000287	0.000501	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-E—type 1 diabetes mellitus	0.000285	0.000497	CbGpPWpGaD
Lithium—GSK3A—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.000284	0.000496	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000283	0.000494	CbGpPWpGaD
Lithium—GSK3A—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000283	0.000494	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000282	0.000493	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000282	0.000493	CbGpPWpGaD
Lithium—IMPA1—Metabolism—ALB—type 1 diabetes mellitus	0.000282	0.000493	CbGpPWpGaD
Lithium—GSK3B—Immune System—LGALS3—type 1 diabetes mellitus	0.000282	0.000492	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000279	0.000487	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000279	0.000487	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—EGFR—type 1 diabetes mellitus	0.000278	0.000486	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—EGFR—type 1 diabetes mellitus	0.000278	0.000486	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—EGFR—type 1 diabetes mellitus	0.000278	0.000486	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD86—type 1 diabetes mellitus	0.000276	0.000482	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—EGFR—type 1 diabetes mellitus	0.000276	0.000481	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000275	0.00048	CbGpPWpGaD
Lithium—GSK3A—Immune System—CTLA4—type 1 diabetes mellitus	0.000274	0.000479	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—EGFR—type 1 diabetes mellitus	0.000274	0.000477	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD80—type 1 diabetes mellitus	0.000273	0.000475	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—EGFR—type 1 diabetes mellitus	0.000272	0.000475	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.000271	0.000473	CbGpPWpGaD
Lithium—IMPA1—Metabolism—NOS3—type 1 diabetes mellitus	0.00027	0.000471	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—TYK2—type 1 diabetes mellitus	0.00027	0.000471	CbGpPWpGaD
Lithium—GSK3B—Immune System—ITPR3—type 1 diabetes mellitus	0.000269	0.00047	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFIH1—type 1 diabetes mellitus	0.000268	0.000467	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD86—type 1 diabetes mellitus	0.000265	0.000462	CbGpPWpGaD
Lithium—GSK3B—Focal Adhesion—EGFR—type 1 diabetes mellitus	0.000263	0.000459	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000263	0.000458	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD79A—type 1 diabetes mellitus	0.000262	0.000457	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD80—type 1 diabetes mellitus	0.000262	0.000456	CbGpPWpGaD
Lithium—GSK3B—Disease—SLC11A1—type 1 diabetes mellitus	0.000261	0.000454	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD40LG—type 1 diabetes mellitus	0.00026	0.000453	CbGpPWpGaD
Lithium—GSK3B—B Cell Activation—EGFR—type 1 diabetes mellitus	0.000258	0.000449	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—HLA-B—type 1 diabetes mellitus	0.000257	0.000449	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD8A—type 1 diabetes mellitus	0.000257	0.000448	CbGpPWpGaD
Lithium—GSK3A—Immune System—PRKCQ—type 1 diabetes mellitus	0.000257	0.000448	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000257	0.000448	CbGpPWpGaD
Lithium—GSK3B—Signaling by SCF-KIT—IL6—type 1 diabetes mellitus	0.000257	0.000448	CbGpPWpGaD
Lithium—GSK3A—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000256	0.000447	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS1—type 1 diabetes mellitus	0.000253	0.000442	CbGpPWpGaD
Lithium—GSK3A—Immune System—VAV1—type 1 diabetes mellitus	0.00025	0.000435	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—ERBB3—type 1 diabetes mellitus	0.000249	0.000434	CbGpPWpGaD
Lithium—GSK3B—Disease—ITPR3—type 1 diabetes mellitus	0.000249	0.000434	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.000248	0.000433	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-B—type 1 diabetes mellitus	0.000247	0.000431	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	0.000247	0.00043	CbGpPWpGaD
Lithium—GSK3B—Downstream signaling of activated FGFR—IL6—type 1 diabetes mellitus	0.000246	0.000428	CbGpPWpGaD
Lithium—GSK3B—Immune System—PTPN2—type 1 diabetes mellitus	0.000245	0.000427	CbGpPWpGaD
Lithium—GSK3B—Immune System—B2M—type 1 diabetes mellitus	0.000242	0.000422	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—CDK4—type 1 diabetes mellitus	0.000242	0.000422	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB4—IL6—type 1 diabetes mellitus	0.000242	0.000422	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000242	0.000421	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—ERBB3—type 1 diabetes mellitus	0.000239	0.000417	CbGpPWpGaD
Lithium—GSK3A—Disease—PRKCQ—type 1 diabetes mellitus	0.000237	0.000414	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000236	0.000411	CbGpPWpGaD
Lithium—GSK3B—Disease—IAPP—type 1 diabetes mellitus	0.000233	0.000406	CbGpPWpGaD
Lithium—GSK3B—Disease—APOC3—type 1 diabetes mellitus	0.000233	0.000406	CbGpPWpGaD
Lithium—GSK3B—Downstream signal transduction—IL6—type 1 diabetes mellitus	0.000231	0.000403	CbGpPWpGaD
Lithium—GSK3A—Disease—VAV1—type 1 diabetes mellitus	0.00023	0.000402	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—TYK2—type 1 diabetes mellitus	0.00023	0.000401	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR—IL6—type 1 diabetes mellitus	0.00023	0.000401	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-A—type 1 diabetes mellitus	0.000229	0.0004	CbGpPWpGaD
Lithium—GSK3B—Signaling by ERBB2—IL6—type 1 diabetes mellitus	0.000229	0.000399	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CRP—type 1 diabetes mellitus	0.000228	0.000397	CbGpPWpGaD
Lithium—GSK3B—DAP12 signaling—IL6—type 1 diabetes mellitus	0.000227	0.000397	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000226	0.000394	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—INS—type 1 diabetes mellitus	0.000225	0.000392	CbGpPWpGaD
Lithium—GSK3B—Disease—B2M—type 1 diabetes mellitus	0.000223	0.00039	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—STAT3—type 1 diabetes mellitus	0.000223	0.000388	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000222	0.000387	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000221	0.000385	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000221	0.000385	CbGpPWpGaD
Lithium—GSK3A—Metabolism of proteins—IGF1—type 1 diabetes mellitus	0.000218	0.00038	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD86—type 1 diabetes mellitus	0.000218	0.00038	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—INS—type 1 diabetes mellitus	0.000215	0.000376	CbGpPWpGaD
Lithium—GSK3B—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000214	0.000373	CbGpPWpGaD
Lithium—GSK3B—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000214	0.000373	CbGpPWpGaD
Lithium—GSK3B—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000214	0.000373	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000214	0.000373	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD40LG—type 1 diabetes mellitus	0.000213	0.000372	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000212	0.00037	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD8A—type 1 diabetes mellitus	0.000211	0.000368	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-E—type 1 diabetes mellitus	0.00021	0.000367	CbGpPWpGaD
Lithium—GSK3B—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.00021	0.000367	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000209	0.000365	CbGpPWpGaD
Lithium—GSK3B—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000209	0.000365	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000209	0.000364	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000209	0.000364	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—CD4—type 1 diabetes mellitus	0.000208	0.000363	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000206	0.00036	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000206	0.00036	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-B—type 1 diabetes mellitus	0.000203	0.000354	CbGpPWpGaD
Lithium—GSK3B—Immune System—CTLA4—type 1 diabetes mellitus	0.000203	0.000354	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD80—type 1 diabetes mellitus	0.000201	0.000351	CbGpPWpGaD
Lithium—GSK3A—Disease—CD86—type 1 diabetes mellitus	0.000201	0.00035	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—CD4—type 1 diabetes mellitus	0.0002	0.000348	CbGpPWpGaD
Lithium—GSK3A—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000197	0.000344	CbGpPWpGaD
Lithium—GSK3A—Immune System—ERBB3—type 1 diabetes mellitus	0.000196	0.000342	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000194	0.000339	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000194	0.000338	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD79A—type 1 diabetes mellitus	0.000193	0.000337	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD80—type 1 diabetes mellitus	0.000193	0.000337	CbGpPWpGaD
Lithium—GSK3B—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000193	0.000337	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000193	0.000336	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TYK2—type 1 diabetes mellitus	0.000192	0.000336	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2RA—type 1 diabetes mellitus	0.00019	0.000332	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKCQ—type 1 diabetes mellitus	0.00019	0.000331	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.00019	0.000331	CbGpPWpGaD
Lithium—GSK3B—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.00019	0.000331	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-A—type 1 diabetes mellitus	0.000188	0.000328	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS1—type 1 diabetes mellitus	0.000187	0.000327	CbGpPWpGaD
Lithium—GSK3B—Immune System—VAV1—type 1 diabetes mellitus	0.000184	0.000322	CbGpPWpGaD
Lithium—GSK3A—Disease—ERBB3—type 1 diabetes mellitus	0.000181	0.000316	CbGpPWpGaD
Lithium—GSK3A—Immune System—CRP—type 1 diabetes mellitus	0.000179	0.000313	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000179	0.000311	CbGpPWpGaD
Lithium—GSK3A—Disease—CCR5—type 1 diabetes mellitus	0.000178	0.000311	CbGpPWpGaD
Lithium—GSK3B—Disease—PRKCQ—type 1 diabetes mellitus	0.000175	0.000306	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000174	0.000304	CbGpPWpGaD
Lithium—GSK3A—Disease—HLA-A—type 1 diabetes mellitus	0.000174	0.000303	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000173	0.000301	CbGpPWpGaD
Lithium—GSK3A—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000172	0.0003	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—EGFR—type 1 diabetes mellitus	0.000172	0.000299	CbGpPWpGaD
Lithium—GSK3B—Disease—VAV1—type 1 diabetes mellitus	0.00017	0.000297	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—TYK2—type 1 diabetes mellitus	0.00017	0.000297	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000167	0.000291	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000166	0.00029	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000164	0.000286	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000163	0.000284	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000163	0.000284	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000161	0.000281	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000161	0.000281	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD86—type 1 diabetes mellitus	0.000161	0.00028	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD80—type 1 diabetes mellitus	0.000159	0.000277	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD40LG—type 1 diabetes mellitus	0.000158	0.000275	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD8A—type 1 diabetes mellitus	0.000156	0.000272	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—type 1 diabetes mellitus	0.000155	0.000271	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—CD4—type 1 diabetes mellitus	0.000154	0.000268	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS2—type 1 diabetes mellitus	0.000151	0.000263	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-B—type 1 diabetes mellitus	0.00015	0.000262	CbGpPWpGaD
Lithium—GSK3B—Disease—CD86—type 1 diabetes mellitus	0.000148	0.000259	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—CD4—type 1 diabetes mellitus	0.000148	0.000258	CbGpPWpGaD
Lithium—GSK3A—Disease—CD80—type 1 diabetes mellitus	0.000147	0.000256	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—EGFR—type 1 diabetes mellitus	0.000146	0.000255	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000146	0.000255	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000146	0.000254	CbGpPWpGaD
Lithium—GSK3B—Immune System—ERBB3—type 1 diabetes mellitus	0.000145	0.000253	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000143	0.00025	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000142	0.000248	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000141	0.000245	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—EGFR—type 1 diabetes mellitus	0.000141	0.000245	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2RA—type 1 diabetes mellitus	0.000141	0.000245	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-A—type 1 diabetes mellitus	0.000139	0.000242	CbGpPWpGaD
Lithium—GSK3A—Disease—INS—type 1 diabetes mellitus	0.000138	0.000242	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—STAT3—type 1 diabetes mellitus	0.000135	0.000235	CbGpPWpGaD
Lithium—GSK3A—Immune System—TYK2—type 1 diabetes mellitus	0.000134	0.000234	CbGpPWpGaD
Lithium—GSK3B—Disease—ERBB3—type 1 diabetes mellitus	0.000134	0.000233	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000133	0.000233	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—type 1 diabetes mellitus	0.000133	0.000231	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—type 1 diabetes mellitus	0.000132	0.00023	CbGpPWpGaD
Lithium—GSK3B—Disease—CCR5—type 1 diabetes mellitus	0.000132	0.00023	CbGpPWpGaD
Lithium—GSK3B—Disease—HLA-A—type 1 diabetes mellitus	0.000128	0.000224	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000128	0.000222	CbGpPWpGaD
Lithium—GSK3B—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000127	0.000221	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000127	0.000221	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNG—type 1 diabetes mellitus	0.000125	0.000219	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000125	0.000218	CbGpPWpGaD
Lithium—GSK3A—Disease—TYK2—type 1 diabetes mellitus	0.000124	0.000216	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000123	0.000214	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000123	0.000214	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—EGFR—type 1 diabetes mellitus	0.000123	0.000214	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—type 1 diabetes mellitus	0.000121	0.000212	CbGpPWpGaD
Lithium—GSK3A—Immune System—CD4—type 1 diabetes mellitus	0.000121	0.000211	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000119	0.000208	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000119	0.000207	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD80—type 1 diabetes mellitus	0.000117	0.000205	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—type 1 diabetes mellitus	0.000117	0.000203	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—type 1 diabetes mellitus	0.000113	0.000196	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—type 1 diabetes mellitus	0.000112	0.000195	CbGpPWpGaD
Lithium—GSK3A—Disease—CD4—type 1 diabetes mellitus	0.000112	0.000195	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS2—type 1 diabetes mellitus	0.000112	0.000195	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL2—type 1 diabetes mellitus	0.000111	0.000194	CbGpPWpGaD
Lithium—GSK3B—Disease—CD80—type 1 diabetes mellitus	0.000108	0.000189	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—EGFR—type 1 diabetes mellitus	0.000108	0.000189	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000108	0.000188	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000104	0.000181	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—EGFR—type 1 diabetes mellitus	0.000104	0.000181	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000103	0.000179	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—type 1 diabetes mellitus	0.000102	0.000178	CbGpPWpGaD
Lithium—GSK3B—Immune System—TYK2—type 1 diabetes mellitus	9.9e-05	0.000173	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.86e-05	0.000172	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—type 1 diabetes mellitus	9.7e-05	0.000169	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—type 1 diabetes mellitus	9.41e-05	0.000164	CbGpPWpGaD
Lithium—GSK3A—Immune System—STAT3—type 1 diabetes mellitus	9.38e-05	0.000164	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.38e-05	0.000164	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.37e-05	0.000164	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNG—type 1 diabetes mellitus	9.27e-05	0.000162	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.22e-05	0.000161	CbGpPWpGaD
Lithium—GSK3B—Disease—TYK2—type 1 diabetes mellitus	9.14e-05	0.000159	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.09e-05	0.000158	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—type 1 diabetes mellitus	8.97e-05	0.000157	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD4—type 1 diabetes mellitus	8.95e-05	0.000156	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.66e-05	0.000151	CbGpPWpGaD
Lithium—GSK3A—Disease—STAT3—type 1 diabetes mellitus	8.66e-05	0.000151	CbGpPWpGaD
Lithium—GSK3A—Immune System—EGFR—type 1 diabetes mellitus	8.53e-05	0.000149	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.5e-05	0.000148	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—type 1 diabetes mellitus	8.31e-05	0.000145	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—type 1 diabetes mellitus	8.27e-05	0.000144	CbGpPWpGaD
Lithium—GSK3B—Disease—CD4—type 1 diabetes mellitus	8.27e-05	0.000144	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL2—type 1 diabetes mellitus	8.24e-05	0.000144	CbGpPWpGaD
Lithium—GSK3A—Disease—EGFR—type 1 diabetes mellitus	7.87e-05	0.000137	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CD80—type 1 diabetes mellitus	7.58e-05	0.000132	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.22e-05	0.000126	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL2—type 1 diabetes mellitus	7.21e-05	0.000126	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—type 1 diabetes mellitus	7.17e-05	0.000125	CbGpPWpGaD
Lithium—GSK3B—Immune System—STAT3—type 1 diabetes mellitus	6.93e-05	0.000121	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.93e-05	0.000121	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—type 1 diabetes mellitus	6.55e-05	0.000114	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.4e-05	0.000112	CbGpPWpGaD
Lithium—GSK3B—Disease—STAT3—type 1 diabetes mellitus	6.4e-05	0.000112	CbGpPWpGaD
Lithium—GSK3B—Immune System—EGFR—type 1 diabetes mellitus	6.3e-05	0.00011	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.28e-05	0.00011	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.07e-05	0.000106	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—type 1 diabetes mellitus	6.05e-05	0.000106	CbGpPWpGaD
Lithium—GSK3B—Disease—EGFR—type 1 diabetes mellitus	5.82e-05	0.000101	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.51e-05	9.62e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.33e-05	9.31e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.33e-05	9.29e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—type 1 diabetes mellitus	4.84e-05	8.45e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.48e-05	7.82e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—type 1 diabetes mellitus	4.47e-05	7.8e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—type 1 diabetes mellitus	4.24e-05	7.39e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.07e-05	7.11e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.13e-05	5.46e-05	CbGpPWpGaD
